The Truth About Mammograms (and Whether You Should Get One)
Rhoads isn't alone. More women are looking at the research on mammography and sidestepping the regular screening guidelines set forth by medical groups. For many years, most healthcare organizations recommended mammograms every one to two years for women 40 and older. But in 2009, there was a major dustup in the conversation surrounding mammography. The U.S. Preventive Services Task Force, an independent panel of medical experts, said screening should occur every two years starting at age 50, citing that research just didn't support the idea that earlier routine testing was actually saving more lives. Nevertheless, groups like the American College of Obstetricians and Gynecologists and the American Cancer Society have maintained that annual mammograms should begin at 40.
While the debate over when to start mammograms continues, opposing medical groups do seem to agree on one thing: Age-based screening is effective. So the decision by some to eschew any sort of uniform policy is being met with resistance. Sue Eull, a 53-year-old registered nurse in Minnesota, for example, says radiology techs have tried to pressure her into getting mammograms—to the point of ushering her into the room with the machine. "Even though I've discussed with my doctor the decision to wait, I've been made to feel like I'm nuts for turning down the test," Eull says.
"A woman saying she doesn't want a mammogram is being wrongly interpreted as though she doesn't care about her body or her health," says leading breast cancer expert Susan Love, MD, founder of the Dr. Susan Love Research Foundation. Love, 66, who herself gets screened every two years, isn't against mammograms, but she is among a growing group of doctors at the forefront of breast cancer prevention and research who are backing away from the one-size-fits-all guidelines. Instead of asking a woman when she wants to schedule a mammogram, says Love, doctors need to ask whether she wants one to begin with. It's an approach that's gaining traction called informed choice, in which each patient weighs the benefits and consequences of screening along with her individual health profile (including any risk factors) under the guidance of a doctor.
Why would any woman want to postpone a test that could save her life? Experts say the risks involved with screening—false positives, overdiagnosis, overtreatment—are becoming increasingly clear. "We've realized that the benefits of mammography may not be as significant as we once thought," says Eric Winer, MD, director of the Breast Oncology Center at Dana-Farber Cancer Institute in Boston and co–chief scientific adviser for Susan G. Komen. Some studies of women who had mammograms in their 40s suggest that the test reduces mortality by as much as 30 to 40 percent, but a new Journal of the American Medical Association (JAMA) report, which combined the results of five recent large-scale clinical trials on mammography, put the reduction at around 15 percent. The researchers also broke down the potential consequences if 10,000 40-year-old women have mammograms every year for ten years: An estimated 190 will be diagnosed with breast cancer. Of those, the test will save about five. Roughly 30 will die because their cancer will prove too aggressive. For the rest, researchers say mammography won't make a difference, in large part because their cancers are slower growing (or will never become invasive) and treatments have improved, making early discovery through mammography less urgent. More than 6,000 of the cancer-free women will be called back with at least one false positive in ten years, potentially undergoing unnecessary biopsies. And any abnormalities that are found will almost always be treated as if they could be deadly, exposing women to treatments—like radiation, surgery, chemo, and hormone therapy—that have their own set of risks. "The problem is that once you identify something, it becomes emotionally very hard not to proceed with some type of treatment," Winer says.
It's impossible to predict exactly how any cancer will behave, but researchers have shown that mammography can lead to unnecessary treatment by comparing the frequency of cancer diagnoses among women who received routine screening and those who didn't (and whose cancer was detected without screening—for instance, when they found a lump). Theoretically, the cancer rates in both groups would come out to be roughly the same, but the JAMA analysis reported that the screening group had an estimated 19 percent higher rate of cancer detection, most likely due to the discovery of growths that, left untreated, wouldn't have posed any health threat. In other words, something else would have killed these women before the cancer ever did.
While breast cancer risk increases with age, there's still a discussion as to whether women need testing every year or even every two. Take, for example, the oft-quoted statistic that a female has a 1-in-8 chance of getting breast cancer in her lifetime; that figure refers to the cancer risk for a girl born today. But if you're 50, your chance of a cancer diagnosis in the next decade is actually closer to 1 in 42. And there's a nearly 99 percent chance that a healthy woman in her early 50s like Caroline Rhoads will be cancer-free for the next five years. If she had a mammogram today, there's a 0.6 percent chance it would reveal cancer and a 12.5 percent chance of a false positive. "As our understanding of the data has evolved," says Winer, "we've learned more about the need to individualize breast cancer screening and treatment."
The personalized approach of informed choice no doubt faces a considerable head wind. There are those with the better-safe-than-sorry mind-set and others who point out that mammography still saves lives. Advocates of informed choice don't want to discount those viewpoints—what they want is for women to consider all the data, which may lead them to rethink testing or go ahead. "Once you have the relevant health information, see how you feel," says Michael Stefanek, PhD, former vice president of behavioral research at the American Cancer Society. "It's an emotional decision as well as an intellectual one."
This is the same conversation Rhoads has with her patients. And she says she'll get tested herself when she believes the benefits of cancer detection outweigh the burden of a false positive, a tipping point that experts acknowledge differs for every woman. Her two older sisters get screened yearly, but her younger sister, who is still in her 40s, has stopped for now. Rhoads adds that she doesn't try to talk anyone into—or out of—a mammogram. "I don't want to subject myself to the risks and stress of false positives if I can avoid it, but another woman might need the reassurance that she's cancer-free. There isn't one right answer. What matters is that each woman makes the best decision for herself and her body."
Laura Beil is a science writer based in the Dallas area.